• Saliva-Based Test to Diagnose Concussions, Blood Test Detects Cancer Two Years Before Formal Diagnosis, More

    Nov 30 | Diagnostics World News | A deep learning model that uses a single chest X-ray to predict the 10-year risk of death from a heart attack or stroke; a new blood test to improve early detection and diagnosis of clinically significant prostate cancer in patients by minimizing unnecessary invasive tissue biopsies; real-time PCR technology to screen for spinal muscular atrophy and severe combined immunodeficiency using a single dried blood spot sample; and more. More

  • Follow the Money: Ultrasensitive ctDNA Personalized Cancer Diagnostic Test, Advanced Brain Cancer Diagnostics, More

    Nov 29 | Diagnostics World News | Funding for chronic kidney disease and acute kidney injury genetic testing, minimal residual disease testing for solid tumors, and more. More

  • Netherlands Hospital to Deploy AI-Assisted Prostate Cancer Diagnostics Suite

    Nov 22 | Diagnostics World News | University Medical Center (UMC) Utrecht in the Netherlands plans to deploy Paige AI applications for routine clinical use and conduct a clinical health economics study to support the adoption and reimbursement of AI applications in pathology. More

  • Clinical Exposomics Emerging As A Foundation For Precision Medicine

    Nov 17 | Diagnostics World News | High-resolution mass spectrometry methods are in principle “good enough” to put into clinics everywhere to measure low-abundance environmental chemicals and start cataloguing individual exposures. With a focus on the “exposome"—the measure of all the exposures of an individual in a lifetime and how those exposures relate to health—healthcare professionals are examining clinical exposomics as a foundation for precision medicine. More

  • AFib Detection With Fitbit-Based Algorithm Nearly Foolproof

    Nov 15 | Diagnostics World News | Fitbit smartwatches and fitness trackers can be outfitted with an algorithm that can detect abnormal heart rhythms. At least that is suggested by findings of a recent study where the algorithm was found to have a high positive predictive value (98%) for atrial fibrillation. More

  • All Hands on Deck: Antimicrobial Stewardship Programs From a Laboratorian’s Perspective

    Nov 11 | Diagnostics World News | After nearly three years of dealing with COVID-19, the last thing anyone wants to hear is news of another looming global health crisis. Unlike COVID-19, this one has been lurking for some time. Scientists, doctors, nurses, pharmacists, and patients have a unique ability and responsibility to address the problem before it gets out of control. The looming crisis is antimicrobial resistance. More

  • Metabolomics Diversity Study Could Help Practitioners Screen for Genetic Diseases

    Nov 10 | Diagnostics World News | A Yale research team discovered that newborn metabolic screening data could identify human ancestry and help practitioners diagnose genetic diseases. More

  • COVID-19 May Increase Risk of Developing Alzheimer’s, Study Suggests

    Nov 08 | Diagnostics World News | A recent study revealed that people ages 65 and older who caught COVID-19 were more likely to develop Alzheimer’s disease shortly thereafter. The findings showed that the risk of developing Alzheimer’s almost doubled in this population of older adults over the one-year period following a COVID-19 diagnosis. More

  • Integrated Host-Microbe Metagenomics Assay Nearly Nails Diagnosis Of Sepsis

    Nov 03 | Diagnostics World News | Diagnosing sepsis is a longstanding challenge in medicine because the clinical signs and symptoms are nonspecific and, in the absence of a gold standard for identifying patients with the disease, the focus has remained largely on identifying the culprit pathogen. But an assay developed by University of California, San Francisco researchers that deploys metagenomic next-generation sequencing of both pathogens and host immune response could be a real gamechanger. More

  • Multianalyte Liquid Biopsy Detects Early-Stage Breast Cancer

    Nov 01 | Diagnostics World News | Robust levels of large extracellular vesicles (LEVs) were found “hiding in plain sight” in the blood of early-stage breast cancer patients in a recent study led by a team of scientists at the University of Southern California. The LEVs are roughly the size of a cell and found while using a high-definition liquid biopsy platform to stratify normal donors from those with early- or late-stage breast cancer. More
View more articles

 
DXX-Industry-spotlight

bioready-citrate-gold-nanoshells


BioReady Citrate Gold Nanoshells

If you are looking for a probe that offers increased sensitivity, lower antibody usage, and the convenience of passive conjugation, you’ve come to the right place. Introducing BioReady Citrate Gold Nanoshells, enabling enhanced sensitivity for your lateral flow assay.

Learn more